Bio-Rad Labs (BIO) Misses Q2 EPS by 52c
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $0.61, $0.52 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $516.8 million versus the consensus estimate of $497.8 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.